Cardlytics (NASDAQ:CDLX) Shares Up 3.3% – Should You Buy?

Cardlytics, Inc. (NASDAQ:CDLX)’s share price traded up 3.3% on Thursday . The stock traded as high as $0.9132 and last traded at $0.8649. 541,740 shares changed hands during trading, a decline of 30% from the average session volume of 768,704 shares. The stock had previously closed at $0.8371.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the stock. Wall Street Zen lowered shares of Cardlytics from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Cardlytics in a report on Monday, December 29th. Three research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Cardlytics currently has an average rating of “Reduce” and an average price target of $2.25.

Cardlytics Stock Up 4.8%

The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 2.87. The company has a 50-day simple moving average of $1.13 and a two-hundred day simple moving average of $1.49. The stock has a market cap of $48.99 million, a P/E ratio of -0.43, a P/E/G ratio of 0.14 and a beta of 1.03.

Cardlytics (NASDAQ:CDLX) last issued its earnings results on Wednesday, November 5th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.08. Cardlytics had a negative net margin of 44.12% and a negative return on equity of 235.70%. The firm had revenue of $52.03 million for the quarter, compared to analysts’ expectations of $56.64 million. On average, equities analysts forecast that Cardlytics, Inc. will post -1.52 EPS for the current year.

Hedge Funds Weigh In On Cardlytics

A number of hedge funds have recently modified their holdings of CDLX. Bank of America Corp DE raised its stake in shares of Cardlytics by 262.7% during the third quarter. Bank of America Corp DE now owns 1,632,786 shares of the company’s stock valued at $3,968,000 after acquiring an additional 1,182,593 shares during the last quarter. Quinn Opportunity Partners LLC raised its position in Cardlytics by 900.0% during the 3rd quarter. Quinn Opportunity Partners LLC now owns 1,100,000 shares of the company’s stock valued at $2,673,000 after purchasing an additional 990,000 shares during the last quarter. Lane Generational LLC raised its position in Cardlytics by 28.0% during the 2nd quarter. Lane Generational LLC now owns 780,083 shares of the company’s stock valued at $1,283,000 after purchasing an additional 170,480 shares during the last quarter. Citizens Financial Group Inc. RI purchased a new stake in Cardlytics in the 3rd quarter worth approximately $1,260,000. Finally, UBS Group AG grew its position in shares of Cardlytics by 112.5% in the 3rd quarter. UBS Group AG now owns 458,066 shares of the company’s stock worth $1,113,000 after buying an additional 242,536 shares during the last quarter. Hedge funds and other institutional investors own 68.10% of the company’s stock.

About Cardlytics

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.